ConditionProgression
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-85
SponsorShanghai Zhongshan Hospital
About this trial
A prospective, two-center, single arm phase II clinical study to evaluate safety and effectiveness of ablation therapy in the treatment of lung cancer presenting as ground-glass nodules
Eligibility criteria
Qualifiers
Aged between 18 and 85 years;
GGO is diagnosed by lung CT and failure to subside after 3 months (the patient having been re-examined by thin-section CT);
The maximum diameter of the GGO is bigger than 8mm and smaller than 3cm;
For single GGO: obvious progress was observed in pure GGO or the solid component of mixed ground glass nodules was more than or equal to 2 mm
Disqualifiers
Patients who participated in any drug and / or medical device clinical trials within one month before the trial
had severe disease conditions
allergy to narcotic drugs
had other autoimmune disease
Trial design
Treatments tested in this trial
- Ablation therapy
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov